Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma 201Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Lymphoma, Non-Hodgkin 112Lymphoma, Large B-Cell, Diffuse 108Leukemia 106Lymphoma, Follicular 93Hodgkin Disease 92Burkitt Lymphoma 91Lymphoma, Mantle-Cell 87Leukemia, Lymphocytic, Chronic, B-Cell 84Lymphoma, Large-Cell, Immunoblastic 73Myelodysplastic Syndromes 63Leukemia, Myeloid, Acute 61Lymphoma, B-Cell, Marginal Zone 59Multiple Myeloma 48Dendritic Cell Sarcoma, Interdigitating 38Recurrence 33Leukemia, Myeloid, Chronic-Phase 33Myeloproliferative Disorders 32Leukemia, Myeloid, Accelerated Phase 32Neoplasms, Plasma Cell 28Blast Crisis 27Leukemia, Myelomonocytic, Chronic 25Lymphoma, Large-Cell, Anaplastic 22Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 21Waldenstrom Macroglobulinemia 20Myelodysplastic-Myeloproliferative Diseases 20Congenital Abnormalities 20Lymphoma, T-Cell, Cutaneous 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19

Interventions

Vincristine 2Rituximab 2Prednisone 2Doxorubicin 2Cyclophosphamide 2pevonedistat 1Filgrastim 1Etoposide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acromesomelic dysplasia, Maroteaux type × Filgrastim × Lymphoid × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡